Monoclonal TCR-redirected tumor cell killingNathaniel Liddy, Bent K. Jakobsen, Tara Mahon et al.|Nature Medicine|2012Cited by 324
High-Affinity TCRs Generated by Phage Display Provide CD4+ T Cells with the Ability to Recognize and Kill Tumor Cell LinesYangbing Zhao, Richard A. Morgan, Alan Bennett et al.|The Journal of Immunology|2007Cited by 216
Structural basis for the killing of human beta cells by CD8+ T cells in type 1 diabetesAnna Bulek, Andrew K. Sewell, David K. Cole et al.|Nature Immunology|2012Cited by 184
Monoclonal TCR-redirected tumor cell killing. Nat MedNathaniel Liddy, Bent K. Jakobsen, Giovanna Bossi et al.|Unknown|2012Cited by 14
Abstract 5616: Soluble, high affinity TCRs fused to anti-CD3 redirect T cells to kill cancer cells presenting MAGE-A3 and NY-ESO antigensNamir J. Hassan, Bent K. Jakobsen, Nathaniel Liddy et al.|Cancer Research|2010Cited by 1